News | Pediatric Imaging | July 18, 2018

Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018

Company will also highlight latest breast imaging, digital X-ray technologies

Fujifilm to Host Pediatric Imaging Best Practices Symposium at AHRA 2018

July 18, 2018 — Fujifilm Medical Systems U.S.A. Inc. announced that it will offer educational opportunities and exhibit its latest innovations in digital radiography (DR), women’s health and pediatric imaging portfolio at the Association for Medical Imaging Management (AHRA) 2018 Annual Meeting and Exposition, July 22-25 in Orlando, Fla.

The company will showcase the following solutions at AHRA 2018:

Aspire Bellus II: The newest smart mammography workstation from Fujifilm offers a multimodality view for radiologists in an exceptional hi-resolution display with integrated 2-D and tomosynthesis reporting. The Aspire Bellus II incorporates key diagnostic features such as current and prior image comparison, quadrant view, tomosynthesis support and inverted image display.

Aspire Cristalle: Fujifilm’s latest digital mammography system features a digital breast tomosynthesis (DBT) option and dose-saving Hexagonal Close Pattern (HCP) image capture technology. The newest solution features innovations to optimize contrast, enable low dose and fast acquisition time, all while providing noticeable patient comfort with the company’s Comfort Paddle.

FDR Go Plus: The FDR Go Plus portable digital X-ray system features a compact design with a new retractable column, at one of the lowest park positions on a full-size portable for easy visibility while traveling. The low profile helps safely navigate tight confined spaces like the emergency room (ER), trauma, operating room (OR) and neonatal intensive care unit (NICU). The redesign brings the lightweight durability of Fujifilm’s FDR D-EVO II detectors and antibacterial protection.

FDR AQRO: The FDR AQRO is a compact portable digital X-ray system designed for dedicated departmental use. FDR AQRO combines Fujifilm’s latest premium advancements in dose saving technologies in a light, maneuverable design. The system features Fujifilm’s Hydro AG Antibacterial Coating on its primary surfaces to provide an added safety measure in infection controls.

Both FDR Go Plus and FDR AQRO are available with the options for kid-friendly graphic decals to help calm patients and their parents during approaching exams.

FDR D-EVO GL: The single exposure 17x49-inch long-length detector enhances workflow for long-view radiography by capturing the entire image in a single exposure in just seconds, reducing the chance for patient motion-induced artifacts and time for the patient to remain still. This new DR imaging is further complemented with the ability to capture its images without a grid utilizing Virtual Grid simulation software, lowering dose up to 50 percent compared to grid exams.

Synapse 5 PACS: Synapse 5 PACS (picture archiving and communication system) is a next-generation, secure server-side technology that enables instant access of massive datasets, working within the most popular browsers while using less bandwidth throughout the enterprise. Enabled with Synapse Communications, healthcare organizations have an enhanced suite of integrated tools including Emergency Department Findings, Results Escalation and Tracking and Radiologist Peer Review. These tools help create a tailored workflow and a closed loop of communication between emergency and radiology departments.

Fujifilm also offers opportunities to learn from radiology and patient care experts at AHRA. For all AHRA attendees, the company will host a complimentary breakfast symposium, Developments in Pediatric Imaging: Best Practices in Dose, Comfort and Safety, focused on reviewing pediatric imaging guidance and sharing best practices in providing the highest quality imaging care for pediatric patients. The educational event will examine the latest technologies for pediatric imaging such as advances in exposure surveillance and dose monitoring, as well as solutions on how to achieve optimum image quality while maintaining patient comfort and safety.

Symposium presenters include:

  • Steven Don, M.D., associate professor of radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine;
  • Robert MacDougall, M.Sc., American Association of Physicists in Medicine (AAPM) Task Group 252 Chair, Boston Children's Hospital; and
  • Gregg Cretella, national director clinical operations, Fujifilm Medical Systems U.S.A. Inc.

In addition, Fujifilm will welcome Nancy M. Cappello, Ph.D., executive director and founder of Are You Dense Inc., to its booth for a question-and-answer session on early detection and patient-centric care. Cappello is a stage 3 breast cancer survivor and patient advocate that is nationally and internationally recognized for her work to pass legislation that mandates the reporting of dense breast tissue to the patient and has built a global grassroots density education and reporting movement.

For more information: www.fujimed.com

Related Content

Infervision's newly FDA approved CT lung AI application sets a new standard
News | Artificial Intelligence | July 10, 2020
July 10, 2020 — Infervision announced U.S.
Simulation finds starting at age 30 with MRI and mammography to be the preferred strategy; starting at 25 prevented marginally more deaths, but with more testing and emotional stress

Getty Images

News | Breast Imaging | July 09, 2020
July 9, 2020 — Chest radiation is used to treat children with Hodgkin and non-Hodgkin lymphoma as well as lung metast
Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
Several drivers will contribute to the growth of the teleradiology market in terms of penetration, revenue and read volumes over the next five years

Getty Images

Feature | Teleradiology | July 08, 2020 | By Arun Gill
Last year was a record year for the global...
This data represents wave 2 of a QuickPoLL survey conducted in partnership with an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business

Getty Images

Feature | Coronavirus (COVID-19) | July 01, 2020 | By Melinda Taschetta-Millane
Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for its head CT scan product qER. The US Food and Drug Administration's decision covers four critical abnormalities identified by Qure.ai's emergency room product.
News | Artificial Intelligence | June 30, 2020
June 30, 2020 — Imaging Artificial Intelligence (AI) provider Qure.ai announced its first US FDA 510(k) clearance for